# US 2008/0306044 A1 · Spirobenzoazepanes as vasopressin antagonists

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306044 A1
- Document ID: US20080306044A1
- Status: Published application
- Kind: A1
- Application number: 12/134,291
- Filed: 2008-06-06
- Published: 2008-12-11
- Earliest claimed: 2007-06-06
- Inventors: MICHAEL J. COSTANZO; David F. McComsey; Stephen C. Yabut; Han-Cheng Zhang
- Web page: https://patentgrep.com/patent/US20080306044A1

## CPC

- C07D 223/32: containing carbocyclic rings other than six-membered
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 7/10: Antioedematous agents; Diuretics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/04: Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 13/00: Drugs for disorders of the urinary system
- A61P 13/10: of the bladder
- A61P 13/12: of the kidneys
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/22: Anxiolytics
- A61P 27/00: Drugs for disorders of the senses
- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention is directed to a compound of Formula (I) or a form thereof: wherein U, V, W and Ring A are as defined herein, useful as vasopressin receptor antagonists.

## Claims

### Claim 1

A compound having the general structure shown in Formula (I):
or a form thereof, wherein,
Ring A is selected from the group consisting Ring R1a, Ring R1b, Ring R1c, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R1h, Ring R1i, Ring R2a, Ring R2b, Ring R2c, Ring R2d, Ring R2e, Ring R2f, Ring R2g, Ring R2h, and Ring R2i, of the formulae:
U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, heterocyclyl or heteroaryl,
wherein heterocyclyl and heteroaryl are each optionally substituted with C1-4alkyl, and
wherein each phenyl is optionally substituted with one, two or three substituents independently selected from C1-4alkyl, C1-4alkoxy, halogen, hydroxy, carboxy, amino, C1-4alkyl-amino or diC1-4alkyl-amino;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, C1-4alkyl-amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, C1-4alkyl-amino-C1-4alkyl-carbonyl-amino, diC1-4alkyl-amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkyl-imino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, C1-4alkyl-amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, C1-4alkyl-amino-C1-4alkoxy-imino, diC1-4alkyl-amino-C1-4alkoxy-imino, heteroaryl, heteroaryl-amino-imino or heteroaryl-carbonyl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl; and,
R2 is oxo, amino, C1-4alkyl-amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl, C1-4alkyl-amino-C1-4alkyl, diC1-4alkyl-amino-C1-4alkyl, amino-C1-4alkyl-amino, C1-4alkyl-amino-C1-4alkyl-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4alkyl-amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, amino-C1-4alkyl-amino-carbonyl-methylene, C1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, heterocyclyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkyl-imino, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, amino-imino, C1-4alkyl-amino-imino, diC1-4alkyl-amino-imino, aryl-oxy-imino, heterocyclyl or heteroaryl, wherein heterocyclyl and heteroaryl are each optionally substituted with C1-4alkyl.

### Claim 2 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1b, Ring R1c, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R1h, Ring R1i, Ring R2a, Ring R2b, Ring R2c, Ring R2d, Ring R2e, Ring R2f, Ring R2g, Ring R2h, and Ring R2i;
U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, pyrrolidinyl or pyrazolyl, wherein pyrazolyl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one, two or three substituents independently selected from C1-4alkyl, C1-4alkoxy, halogen, hydroxy, carboxy, amino, C1-4alkyl-amino or diC1-4alkyl-amino;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, C1-4alkyl-amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, C1-4alkyl-amino-C1-4alkyl-carbonyl-amino, diC1-4alkyl-amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkyl-imino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, C1-4alkyl-amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, C1-4alkyl-amino-C1-4alkoxy-imino, diC1-4alkyl-amino-C1-4alkoxy-imino, 1H-imidazolyl, pyridinyl-amino-imino or pyridinyl-carbonyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl; and,
R2 is oxo, amino, C1-4alkyl-amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl, C1-4alkyl-amino-C1-4alkyl, diC1-4alkyl-amino-C1-4alkyl, amino-C1-4alkyl-amino, C1-4alkyl-amino-C1-4alkyl-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4alkyl-amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, amino-C1-4alkyl-amino-carbonyl-methylene, C1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, morpholinyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkyl-imino, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, amino-imino, C1-4alkyl-amino-imino, diC1-4alkyl-amino-imino, aryl-oxy-imino, pyrrolidinyl, piperazinyl, 4,5-dihydro-1H-imidazolyl, morpholinyl, tetrazolyl or 1H-imidazolyl, wherein piperazinyl and heteroaryl are each optionally substituted with C1-4alkyl.

### Claim 3 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R2b, Ring R2e and Ring R2h;
U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, heterocyclyl or heteroaryl, wherein heteroaryl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, heteroaryl, heteroaryl-amino-imino or heteroaryl-carbonyl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl; and,
R2 is oxo, amino, diC1-4alkyl-amino, hydroxy-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, heterocyclyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, heterocyclyl or heteroaryl, wherein heterocyclyl is optionally substituted with C1-4alkyl.

### Claim 4 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R2b, Ring R2e and Ring R2h;
U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, pyrrolidinyl or pyrazolyl, wherein pyrazolyl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, 1H-imidazolyl, pyridinyl-amino-imino or pyridinyl-carbonyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl; and,
R2 is oxo, amino, diC1-4alkyl-amino, hydroxy-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, morpholinyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, pyrrolidinyl, piperazinyl, 4,5-dihydro-1H-imidazolyl, morpholinyl, tetrazolyl or 1H-imidazolyl, wherein piperazinyl is optionally substituted with C1-4alkyl.

### Claim 5 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R2b, Ring R2e and Ring R2h;
U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, heterocyclyl or heteroaryl, wherein heteroaryl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, heteroaryl, heteroaryl-amino-imino or heteroaryl-carbonyl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl; and,
R2 is diC1-4alkyl-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, heterocyclyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, heterocyclyl or heteroaryl.

### Claim 6 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R2b, Ring R2e and Ring R2h;
U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, pyrrolidinyl or pyrazolyl, wherein pyrazolyl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, 1H-imidazolyl, pyridinyl-amino-imino or pyridinyl-carbonyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl; and,
R2 is diC1-4alkyl-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, morpholinyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino4,5-dihydro-1H-imidazolyl, morpholinyl, tetrazolyl or 1H-imidazolyl.

### Claim 7 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1g, Ring R2b, Ring R2e and Ring R2h;
U is phenyl-carbonyl-amino or biphenyl-carbonyl-amino, wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, heteroaryl, heteroaryl-amino-imino or heteroaryl-carbonyl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl; and,
R2 is amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, hydroxy-imino or heteroaryl.

### Claim 8 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1g, Ring R2b, Ring R2e and Ring R2h;
U is phenyl-carbonyl-amino or biphenyl-carbonyl-amino, wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen;
V is CH or N;
W is hydrogen or C1-3alkoxy;
R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, 1H-imidazolyl, pyridinyl-amino-imino or pyridinyl-carbonyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl; and,
R2 is amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, hydroxy-imino, tetrazolyl or 1H-imidazolyl.

### Claim 9 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1d, Ring R1e and Ring R1g;
U is phenyl-carbonyl-amino, wherein phenyl is substituted with one or two halogen substituents;
V is CH;
W is hydrogen; and,
R1 is C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, heteroaryl, or heteroaryl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl.

### Claim 10 (depends on 1)

The compound of claim 1, wherein
Ring A is selected from the group consisting Ring R1d, Ring R1e and Ring R1g;
U is phenyl-carbonyl-amino, wherein phenyl is substituted with one or two halogen substituents;
V is CH;
W is hydrogen; and,
R1 is C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, 1H-imidazolyl or pyridinyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl.

### Claim 11 (depends on 1)

The compound of claim 1, wherein Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1f, Ring R1g, Ring R2b, Ring R2e and Ring R2h.

### Claim 12 (depends on 1)

The compound of claim 1, wherein Ring A is selected from the group consisting Ring R1a, Ring R1d, Ring R1e, Ring R1g, Ring R2b, Ring R2e and Ring R2h.

### Claim 13 (depends on 1)

The compound of claim 1, wherein Ring A is selected from the group consisting Ring R1d, Ring R1e and Ring R1g.

### Claim 14 (depends on 1)

The compound of claim 1, wherein U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, heterocyclyl or heteroaryl, wherein heteroaryl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen.

### Claim 15 (depends on 1)

The compound of claim 1, wherein U is phenyl-carbonyl-amino, biphenyl-carbonyl-amino, pyrrolidinyl or pyrazolyl, wherein pyrazolyl is optionally substituted with C1-4alkyl, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen.

### Claim 16 (depends on 1)

The compound of claim 1, wherein U is phenyl-carbonyl-amino or biphenyl-carbonyl-amino, and wherein each phenyl is optionally substituted with one or two substituents independently selected from C1-4alkyl or halogen.

### Claim 17 (depends on 1)

The compound of claim 1, wherein U is phenyl-carbonyl-amino, and wherein phenyl is substituted with one or two halogen substituents.

### Claim 18 (depends on 1)

The compound of claim 1, wherein V is CH.

### Claim 19 (depends on 1)

The compound of claim 1, wherein W is hydrogen.

### Claim 20 (depends on 1)

The compound of claim 1, wherein R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, heteroaryl, heteroaryl-amino-imino or heteroaryl-carbonyl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl.

### Claim 21 (depends on 1)

The compound of claim 1, wherein R1 is amino, diC1-4alkyl-amino, hydroxy-amino, amino-C1-4alkyl-carbonyl-amino, amino-sulfonyl-amino, C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, 1H-imidazolyl, pyridinyl-amino-imino or pyridinyl-carbonyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl.

### Claim 22 (depends on 1)

The compound of claim 1, wherein R1 is C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, heteroaryl, or heteroaryl-amino-imino, wherein each heteroaryl is optionally substituted with C1-4alkyl.

### Claim 23 (depends on 1)

The compound of claim 1, wherein R1 is C1-4alkoxy-imino, hydroxy-imino, amino-imino, diC1-4alkyl-amino-imino, amino-C1-4alkoxy-imino, 1H-imidazolyl or pyridinyl-amino-imino, wherein 1H-imidazolyl is optionally substituted with C1-4alkyl.

### Claim 24 (depends on 1)

The compound of claim 1, wherein R2 is oxo, amino, diC1-4alkyl-amino, hydroxy-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, heterocyclyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, heterocyclyl or heteroaryl, wherein heterocyclyl is optionally substituted with C1-4alkyl.

### Claim 25 (depends on 1)

The compound of claim 1, wherein R2 is oxo, amino, diC1-4alkyl-amino, hydroxy-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, morpholinyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, pyrrolidinyl, piperazinyl, 4,5-dihydro-1H-imidazolyl, morpholinyl, tetrazolyl or 1H-imidazolyl, wherein piperazinyl is optionally substituted with C1-4alkyl.

### Claim 26 (depends on 1)

The compound of claim 1, wherein R2 is diC1-4alkyl-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, heterocyclyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, heterocyclyl or heteroaryl.

### Claim 27 (depends on 1)

The compound of claim 1, wherein R2 is diC1-4alkyl-amino, diC1-4alkyl-amino-C1-4alkyl-amino, amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, diC1-4alkyl-amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, diC1-4alkyl-amino-C1-4alkyl-amino-carbonyl-methylene, heterocyclyl-C1-4alkyl-amino-carbonyl-methylene, C1-4alkoxy-imino, hydroxy-imino, carboxy-C1-4alkoxy-imino, diC1-4alkyl-amino-imino, 4,5-dihydro-1H-imidazolyl, morpholinyl, tetrazolyl or 1H-imidazolyl.

### Claim 28 (depends on 1)

The compound of claim 1, wherein R2 is amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, hydroxy-imino or heteroaryl.

### Claim 29 (depends on 1)

The compound of claim 1, wherein R2 is amino-sulfonyl-amino, amino-sulfonyl-amino-carbonyl, C1-4alkoxy-carbonyl-methylene, carboxy-methylene, amino-carbonyl-methylene, C1-4alkyl-amino-carbonyl-methylene, hydroxy-C1-4alkyl-amino-carbonyl-methylene, hydroxy-imino, tetrazolyl or 1H-imidazolyl.

### Claim 30

A compound selected from the group consisting of:
2-aminoimino-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-methoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-3-ylcarbonylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(1-methyl-1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylamino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[6-(2-chloro-5-fluoro-phenylcarbonyl)amino-pyridin-3-ylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-tetrazol-5-yl-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(4,5-dihydro-1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-3-aminosulfonylaminocarbonyl-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-carboxymethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-3-amino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-morpholin-4-yl-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-dimethylamino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-dimethylamino-ethyl)amino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(4-methyl-piperazin-1-yl)-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-carboxymethoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(1H-pyrrolidin-1-yl)-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methoxycarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-dimethylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-morpholin-4-yl-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-hydroxy-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methylaminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-dimethylamino-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-3-aminocarbonylmethylene-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R,3S)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R,3R)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-[(dimethylaminosulfonyl)aminocarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-aminoimino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-(aminomethylcarbonyl)amino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(2-amino-ethoxy)imino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-2-ylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(S)-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-pyrrolidin-1-yl-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(3-methyl-1H-pyrazol-1-yl)-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-methyl-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-methyl-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[3-methoxy-4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-3-aminosulfonylaminocarbonyl-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane], and
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-oxo-spiro[cyclopentane-1,4′-benzo[b]azepane].

### Claim 31 (depends on 30)

The compound of claim 30, wherein the compound is selected from the group consisting of:
2-aminoimino-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-methoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-3-ylcarbonylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(1-methyl-1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylamino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[6-(2-chloro-5-fluoro-phenylcarbonyl)amino-pyridin-3-ylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-tetrazol-5-yl-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(4,5-dihydro-1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-3-aminosulfonylaminocarbonyl-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-carboxymethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-morpholin-4-yl-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-dimethylamino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-dimethylamino-ethyl)amino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-carboxymethoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methoxycarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-dimethylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-morpholin-4-yl-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-hydroxy-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methylaminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-dimethylamino-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-3-aminocarbonylmethylene-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane], 2-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R,3S)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R,3R)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-[(dimethylaminosulfonyl)aminocarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-aminoimino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-(aminomethylcarbonyl)amino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(2-amino-ethoxy)imino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-2-ylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(S)-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-pyrrolidin-1-yl-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(3-methyl-1H-pyrazol-1-yl)-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-methyl-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-methyl-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[3-methoxy-4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane], and
(R)-3-aminosulfonylaminocarbonyl-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane].

### Claim 32 (depends on 31)

The compound of claim 31, wherein the compound is selected from the group consisting of:
2-aminoimino-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-methoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-3-ylcarbonylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(1-methyl-1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylamino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[6-(2-chloro-5-fluoro-phenylcarbonyl)amino-pyridin-3-ylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-tetrazol-5-yl-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-3-aminosulfonylaminocarbonyl-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-carboxymethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methoxycarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-(2-hydroxy-ethyl)aminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-3-methylaminocarbonylmethylene-spiro[cyclopentane-1,4′-benzo[b]azepane],
(R)-3-aminocarbonylmethylene-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
(1R,3R)-3-aminosulfonylamino-N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-aminoimino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-amino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
2-(aminomethylcarbonyl)amino-N-[4-(biphen-2-ylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(2-amino-ethoxy)imino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-2-ylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-methyl-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-methyl-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[3-methoxy-4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane], and
(R)-3-aminosulfonylaminocarbonyl-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane].

### Claim 33 (depends on 32)

The compound of claim 32, wherein the compound is selected from the group consisting of:
2-aminoimino-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-methoxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-dimethylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(1-methyl-1H-imidazol-2-yl)-spiro[cyclopent-2-ene-1,4′-benzo[b]azepane],
(R)-N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(3-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-(2-amino-ethoxy)imino-spiro[cyclopentane-1,4′-benzo[b]azepane],
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-pyridin-2-ylaminoimino-spiro[cyclopentane-1,4′-benzo[b]azepane], and
N-[4-(2-chloro-5-fluoro-phenylcarbonyl)amino-phenylcarbonyl]-2-hydroxyimino-spiro[cyclopentane-1,4′-benzo[b]azepane].

### Claim 34 (depends on 1)

The compound of claim 1, wherein the compound is an isolated form.

### Claim 35 (depends on 1)

A pharmaceutical composition comprising at least one compound of claim 1, in combination with at least one pharmaceutically acceptable carrier or excipient.

### Claim 36 (depends on 30, 35)

The pharmaceutical composition of claim 35, wherein the composition comprises at least one compound of claim 30.

### Claim 37 (depends on 1)

A process for making a pharmaceutical composition comprising mixing a compound of claim 1 and a pharmaceutically acceptable carrier.

### Claim 38 (depends on 1)

A method for treating a vasopressin receptor mediated condition in a patient in need thereof comprising the step of administering to the patient an effective amount of the compound of claim 1.

### Claim 39 (depends on 38)

The method of claim 38, wherein the vasopressin receptor is the vasopressin 1 a receptor, the vasopressin 2 receptor or both the vasopressin 1a and vasopressin 2 receptors.

### Claim 40 (depends on 38)

The method of claim 38, wherein the vasopressin receptor mediated condition is selected from edema, ischemia, inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, hyponatremia, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, polycystic kidney disease, diabetic nephropathy, cerebral edema and ischemia, stroke, thrombosis, water retention, aggression, obsessive-compulsive disorders, dysmenorrhea, nephrotic syndrome, anxiety and central nervous injuries.

### Claim 41 (depends on 40)

The method of claim 40, wherein the condition is selected from hypertension, congestive heart failure, cardiac insufficiency, diabetic nephropathy, dysmenorrhea, renal failure, hyponatremia or stroke.

### Claim 42 (depends on 40)

The method of claim 40, wherein the condition is selected from congestive heart failure, diabetic nephropathy, dysmenorrhea, renal failure or hyponatremia.

### Claim 43 (depends on 40)

The method of claim 40, wherein the effective amount is from about 0.001 mg/kg/day to about 300 mg/kg/day.

### Claim 44 (depends on 1)

A use of the compound of claim 1 in the manufacture of a medicament for treating a vasopressin receptor mediated condition.

### Claim 45 (depends on 44)

The use of claim 44, wherein the vasopressin receptor mediated condition is selected from edema, ischemia, inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, hyponatremia, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, polycystic kidney disease, diabetic nephropathy, cerebral edema and ischemia, stroke, thrombosis, water retention, aggression, obsessive-compulsive disorders, dysmenorrhea, nephrotic syndrome, anxiety and central nervous injuries.

### Claim 46 (depends on 1)

A use of the compound of claim 1 as a medicine.
